Phase 2 Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be willing and able to sign a consent form before taking part in the study
- You must be 18 years of age or older (male or female as assigned at birth) at the time of your screening visit
- You must have been diagnosed with non-segmental vitiligo (a specific type of vitiligo), confirmed by a physical examination by the study doctor
- You must have vitiligo affecting at least 0.5% of the surface area of your face, with a minimum face-specific severity score of 0.5 (confirm with trial site)
- You must also have vitiligo covering at least 3% of your body surface area on non-facial areas, not counting the hands and feet, with an overall severity score between 3 and 60 (confirm with trial site)
Who may not be able to join:
- People who are unwilling or unable to follow the study procedures or complete the study questionnaires
- People who have a different type of vitiligo (such as segmental or mixed vitiligo), or other skin conditions that could affect how the study results are measured
- People who have previously been treated with a biologic drug that specifically targets a protein called IL-15 or its receptors (confirm with trial site)
- People who have previously tried or completed a treatment specifically designed to remove all remaining skin pigment (depigmentation therapy)
- People who are currently using certain medications or treatments that are not allowed during this study (confirm with trial site for the full list)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-888-669-6682
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percentage change from baseline in Facial Vitiligo Area Scoring Index (F-VASI) score.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.